RECRUITING

The COMPASSION Study

Talk to us

Conditions

Breast CancerMetastatic Breast CancerAdvanced Breast CancerUnresectable Breast CarcinomaUnresectable Breast CancerHospice Care

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Official Title

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients with Metastatic Breast Cancer Receiving Hospice Care

Quick Facts

Study Start:2024-09-01
Study Completion:2026-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06507930

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient of any gender with unresectable locally advanced or metastatic breast cancer
  2. * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment
  3. * Ability to conduct video or phone check-ins, even if assistance required.
  4. * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
  5. * Hospice setting is within Massachusetts
  6. * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
  7. * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment
  1. * Unable to provide verbal consent
  2. * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
  3. * Hospice setting outside of Massachusetts
  4. * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Contacts and Locations

Study Contact

Claire Smith, MD
CONTACT
617-632-3800
claire_smith@dfci.harvard.edu

Principal Investigator

Claire Smith, MD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Claire Smith, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-01
Study Completion Date2026-03-01

Study Record Updates

Study Start Date2024-09-01
Study Completion Date2026-03-01

Terms related to this study

Keywords Provided by Researchers

  • Breast Cancer
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • Unresectable Breast Cancer
  • Hospice Care

Additional Relevant MeSH Terms

  • Breast Cancer
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • Unresectable Breast Carcinoma